{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:27:38Z","timestamp":1782602858496,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.4158\/ep09286.cr","type":"journal-article","created":{"date-parts":[[2010,5,24]],"date-time":"2010-05-24T21:02:58Z","timestamp":1274734978000},"page":"829-834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Long-Term Management with Octreotide or Cabergoline in Ectopic Corticotropin Hypersecretion: Case Report and Literature Review"],"prefix":"10.1016","volume":"16","author":[{"given":"Oscar D.","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Danilowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Manavela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Mana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP09286.CR_bb0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2265.1986.tb01667.x","article-title":"Diagnosis and management of ACTH-dependent Cushing's syndrome: Comparison of the features in ectopic and pituitary ACTH production","volume":"24","author":"Howlett","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP09286.CR_bb0015","first-page":"641","article-title":"Functional tumors with special reference to ectopic hormone producing tumors [article in Japanese]","volume":"23","author":"Imura","year":"1978","journal-title":"Tanpakushitsu Kakusan Koso"},{"key":"10.4158\/EP09286.CR_bb0020","first-page":"752","article-title":"Ectopic adrenocorticotropic hormone syndrome","volume":"15","author":"Wajchenberg","year":"1994","journal-title":"Endocr Rev"},{"key":"10.4158\/EP09286.CR_bb0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","article-title":"The medical treatment of Cushing's disease: Effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery","volume":"94","author":"Pivonello","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09286.CR_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1210\/jc.2006-0728","article-title":"Dopamine receptor expression and function in corticotroph ectopic tumors","volume":"92","author":"Pivonello","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09286.CR_bb0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0889-8529(05)70209-7","article-title":"Diagnosis and differential diagnosis of Cushing's syndrome","volume":"30","author":"Findling","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP09286.CR_bb0040","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing's syndrome due to ectopic corticotropin secretion: Twenty years' experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09286.CR_bb0045","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1210\/jc.2006-0997","article-title":"Cushing's syndrome: Important issues in diagnosis and management","volume":"91","author":"Findling","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09286.CR_bb0050","first-page":"20","article-title":"Somatostatin analogs for the localization and the preoperative treatment of an adrenocorticotropin secreting bronchial carcinoid tumor","volume":"78","author":"Phlipponneau","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09286.CR_bb0055","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1210\/jc.2001-011813","article-title":"Management of occult adrenocorticotropin-secreting bronchial carcinoids: Limits of endocrine testing and imaging techniques","volume":"88","author":"Loli","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09286.CR_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0026-0495(96)90107-9","article-title":"Somatostatin analogs in ectopic corticotropin production","volume":"45","author":"von Werder","year":"1996","journal-title":"Metabolism"},{"key":"10.4158\/EP09286.CR_bb0065","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1152\/ajpendo.00004.2005","article-title":"Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells","volume":"289","author":"van der Hoek","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.4158\/EP09286.CR_bb0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/edrv-14-4-443","article-title":"The medical treatment of Cushing's syndrome","volume":"14","author":"Miller","year":"1993","journal-title":"Endocr Rev"},{"key":"10.4158\/EP09286.CR_bb0075","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/gut.29.6.838","article-title":"Long acting somatostatin treatment of paraneoplastic Cushing's syndrome in a case of Zollinger-Ellison syndrome","volume":"29","author":"Ruszniewski","year":"1988","journal-title":"Gut"},{"key":"10.4158\/EP09286.CR_bb0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0002-9343(93)90283-U","article-title":"Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome","volume":"95","author":"Woodhouse","year":"1993","journal-title":"Am J Med"},{"key":"10.4158\/EP09286.CR_bb0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0029-1211252","article-title":"Successful treatment of ectopic Cushing's syndrome with the long-acting somatostatin analog octreotide","volume":"101","author":"De Rosa","year":"1993","journal-title":"Exp Clin Endocrinol"},{"key":"10.4158\/EP09286.CR_bb0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.1998.00510.x","article-title":"Occult ectopic ACTH secretion due to recurrent lung carcinoid: Long-term control of hypercortisolism by continuous subcutaneous infusion of octreotide","volume":"49","author":"Van den Bruel","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP09286.CR_bb0095","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/BF03347351","article-title":"Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome?","volume":"26","author":"Uwaifo","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP09286.CR_bb0100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2265.1992.tb01461.x","article-title":"Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours","volume":"36","author":"Cheung","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP09286.CR_bb0105","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s11606-008-0587-z","article-title":"Cushing's syndrome due to ectopic adrenocorticotropic hormone production secondary to hepatic carcinoid: Diagnosis, treatment and improved quality of life","volume":"23","author":"Coe","year":"2008","journal-title":"J Gen Intern Med"},{"key":"10.4158\/EP09286.CR_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000182737","article-title":"Paradoxical effect of somatostatin analogues on the ectopic secretion of corticotrophin in two cases of small cell lung carcinoma","volume":"39","author":"Rieu","year":"1993","journal-title":"Horm Res"},{"key":"10.4158\/EP09286.CR_bb0115","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1210\/jc.2003-030837","article-title":"Dopamine receptor expression and function in corticotroph pituitary tumors","volume":"89","author":"Pivonello","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09286.CR_bb0120","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJM200506093522322","article-title":"Cabergoline plus lanreotide for ectopic Cushing's syndrome","volume":"352","author":"Pivonello","year":"2005","journal-title":"N Engl J Med"},{"key":"10.4158\/EP09286.CR_bb0125","series-title":"Neuro-active Drugs in Endocrinology","first-page":"371","article-title":"Bromocriptine and the medical treatment of Cushing's disease","author":"Lamberts","year":"1980"},{"key":"10.4158\/EP09286.CR_bb0130","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archinte.1987.00370050181031","article-title":"Prolonged suppression of a corticotropin-producing bronchial carcinoid by oral bromocriptine","volume":"147","author":"Reith","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP09286.CR_bb0135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF03344109","article-title":"Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: Spontaneous remission or therapeutic effect of bromocriptine?","volume":"29","author":"Francia","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP09286.CR_bb0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.288.5463.154","article-title":"Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity","volume":"288","author":"Rocheville","year":"2000","journal-title":"Science"},{"key":"10.4158\/EP09286.CR_bb0145","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000095536","article-title":"Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas","volume":"83","author":"Saveanu","year":"2006","journal-title":"Neuroendocrinology"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20415174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20415174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/7352215H7087H325.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:51:36Z","timestamp":1761515496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20415174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1530891X20415174"],"URL":"https:\/\/doi.org\/10.4158\/ep09286.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Management with Octreotide or Cabergoline in Ectopic Corticotropin Hypersecretion: Case Report and Literature Review","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP09286.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}